Effects of lenalidomide and dexamethasone treatment duration on survival in patients with relapsed or refractory multiple myeloma treated with lenalidomide and dexamethasone

  1. San-Miguel, J.F.
  2. Dimopoulos, M.A.
  3. Stadtmauer, E.A.
  4. Rajkumar, S.V.
  5. Siegel, D.
  6. Bravo, M.-L.
  7. Olesnyckyj, M.
  8. Knight, R.D.
  9. Zeldis, J.B.
  10. Harousseau, J.-L.
  11. Weber, D.M.
Aldizkaria:
Clinical Lymphoma, Myeloma and Leukemia

ISSN: 2152-2650 2152-2669

Argitalpen urtea: 2011

Alea: 11

Zenbakia: 1

Orrialdeak: 38-43

Mota: Artikulua

DOI: 10.3816/CLML.2010.N.120 GOOGLE SCHOLAR

Garapen Iraunkorreko Helburuak